ISPOR Spain Chapter Meeting
May 20, 2020
Since the last chapter meeting, the Spain Chapter has organized 2 courses and 4 seminars. The chapter has established 2 collaboration agreements with other associations, FENIN and AEFI, with others are in process. The chapter website has been updated. The chapter's Strategic Plan for the next 3 years has been finalized.
Health System and COVID-19 - ISPOR Spain Chapter Perspectives
As of March 29, 2020
Spain had on March 29, 2020, 85,195 confirmed cases with 7340 accumulated deaths*. The number of deaths in Spain are skyrocketing more rapidly than they did in China. Up to date, diagnosis test is only indicating if a person has symptoms and has been in contact with a confirmed or probable case during the last 14 days. Spain has 4,400 ICU beds (3,500 public and 900 private) and typically the occupation index is around 75%. This could create a situation of over demand of ICU beds and, if the situation is out of control, the collapse of the whole NHS may be a fact. In order to relieve pressure from the hospitals, Madrid and Catalonia turned conference centres and big hotels into facilities treating mild to severe COVID-19 cases. Many hospitals across the country are being fully transformed into COVID-19 patient care centres and many ICUs are being created from the existing facilities.
In order to control the incidence, on March 14th the government declared the state of alarm, which regulates the limitation to the citizens´ movement and gives the government “extraordinary powers” to guarantee “maximum coordination” to face the virus and protect the population. The state of alarm is extended until 11th of April, with a complete lockdown from 30th of March to 9th of April. All health services, military, private and public, are now under the control of the Ministry of Health, in coordination with the regional health services. Additionally, a package to pump €214 billion into the economy, to address economic and social impact of coronavirus was announced, which represents almost 20% of GDP. Moreover, €30 million will be allocated to investigate a COVID-19 vaccine, together with other preventive, diagnostic and therapeutic tools. The 3 pillars for purchasing by the health care system include: personal protective equipment; respirators and ventilators; and rapid diagnostic tests. Local health companies must produce essential medicines & devices to fight COVID-19.
*Source: Ministry of Health, Spain. https://covid19.isciii.es/
Digital Transformation in Healthcare: New Roles & Shared Responsibilities
January 29, 2020, Madrid Medical College, Madrid, Spain
The event was inspired by the ISPOR Europe 2019 conference in November 2019 and was organized into roundtables dedicated to: Pricing and Reimbursement (P&R) System in Spain and Spanish National Health System Advances in Digitalization.
First table on P&R concluded with the need for more investments in the health system, the usefulness of the agreement between the pharmaceutical industry and the General State Administration, sustainability policies and transparency of prices.
The Spanish National Health System and regional services have made a considerable progress in digitalization and data usage over the past few years. This has been demonstrated by recent advances in electronic prescriptions, electronic medical records and other projects launched locally, for example in the field of telemedicine or the creation of health catalogues available to patients. However, for maximum benefits, there are still areas of improvement. The most important is related to the integration of different information systems, including health outcomes records. The key to improving in all these areas are the political interest, investments and professional involvement.
They concluded that there is a need to create a culture of health measurement and believe that systems should be ‘linked to professionals’ in their daily practice, and thus avoiding repetition.
ISPOR Spain Chapter Meeting at ISPOR Europe 2019, Copenhagen, Denmark
Agenda for Price and Reimbursement Reforms in Spain
The reforms in the system of price and reimbursement in Spain were analyzed during the ISPOR Spain Chapter meeting at the ISPOR Europe 2019 conference in Copenhagen, Denmark held 2-6 November 2019.
The meeting was attended by the Deputy Director of Drug Quality of the Ministry of Health, Dolores Fraga, the economist at the International University of Catalonia and member of the Pharmaceutical Benefits Advisory Council, Marta Trapero-Bertran and the director of the Department of Studies of Farmaindustria, Pedro Luis Sánchez. The meeting was moderated by Carme Pinyol, the President of the ISPOR Spain Chapter.
Issues of interest such as Valtermed, the role of economic evaluation in the process of pricing and future challenges in pharmaceutical spending, as well as the transparency of drug prices were addressed throughout this session.
In relation to Valtermed, the speakers highlighted the value and usefulness of this database created by the Ministry of Health as a facilitator of innovation access. On the other hand, it was pointed out that the current problem regarding the evaluation of health outcomes does not lie in the availability of patient data but in the ability to evaluate and analyze the data obtained through this database. A possibility that requires technical and human resources by the Ministry of Health, which would mean a handicap.
In addition, throughout the debate the need to ensure the quality of the data entered as well as the involvement of the health professionals in this process was mentioned. This was one of the critical points discussed in this section. It was also raised in need of somehow encouraging health professionals, which could be one of the formulas to solve these problems.
The second issue addressed during the meeting was the role of economic evaluation in relation to pricing of medicines and the role of the Advisory Committee on the Reimbursement of Pharmaceutical Provision. Marta Trapero-Bertran began by explaining the functions of the advisory committee, emphasizing that it is purely technical and advisory committee of the General Directorate of Basic Portfolio of Services and Pharmacy is not a drug evaluation body.
As she indicated, their main task is to advise on the documents which the Ministry is currently working on and those that have already been published, as is the case of the Generic and Biosimilar Plan that has recently seen the light. Trapero-Bertran He also noted that, from her perspective, this is the first time that the Ministry of Health is concerned and occupies in the economic evaluation of medicines despite the few human resources available to it. On the part of Farmaindustria, Sánchez demanded more transparency in the procedures for economic evaluation to reduce uncertainty and to facilitate the quality of the studies provided by the pharmaceutical industry.
Future challenges on pharmaceutical spending was the third topic discussed. Dolores Fraga said that “the biggest challenge is the incorporation of all the innovation we have and that in the near future we will have guaranteeing the sustainability of the system”. In this regard, the representative of the Ministry also raised the need to take necessary measures to plan the incorporation of this innovation. This would be achieved by reducing uncertainty at the time of entering new medicines.
Fraga said that the adoption of measures that facilitate the incorporation of new medicines is also necessary, using as an example of the Generic and Biosimilar Medicine Plan. As commented by Farmaindustria, the exercise of Horizon Scanning is essential to be able to carry out this planning in the medium and long term considering what is the next innovation, but also to know what is the gap that is left by the entry of new generic drugs and Biosimilars
In addition, Trapero-Bertran explained that the education and awareness of health professionals and citizens is the key to claiming the proactivity of the pharmaceutical industry on this issue.
Workshop on Methodology in Evaluating Medical Devices
19 November 2019, Madrid, Spain
On the 19th of November, a workshop about GRADE methodology to assess the quality of evidence for medical devices was held in Madrid. This workshop organized by the ISPOR Spain Chapter focused on the key aspects of this methodology and the specific issues when medical devices are evaluated.
The workshop was organized by the two Chapter management members: Paloma Gonzalez García and Carlos Martín Saborido. Dr Jesús López Alcalde (Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS) / Universidad Francisco de Vitoria) and Desiré Rodriguez Bezos (Boston Scientific Iberica) who also collaborated on the development of this workshop.
The workshop was organized into three sessions:
- Introduction to GRADE methodology and Classification of medical devices
- Use of GRADE within medical devices framework and differences between drugs and medical devices
- Work by groups
There were 9 attendants to the workshop covering medical devices manufacturers, consultancy and drug manufacturers. The ISPOR Spain Chapter sent documentation to all attendees to introduce GRADE concept and to have a homogeneous knowledge about the topic covered in the workshop.
A final document with key points about the use of GRADE in medical devices and insights from the attendees will be produced following the workshop.
“New Perspectives to Improve Health Systems of the 21 Century”
March 26, 2019
The chapter participated in a meeting with a local Ministry of Health, "New Perspectives to Improve Health Systems of the 21st Century.” Topics of the discussion included new funding models for medicines and healthcare technologies that allow technological innovations and maintaining the sustainability of the health system. Among speakers were representatives of public health organizations and academic institutions in Spain.
Multi-Criteria Decision Analysis (MCDA) Workshop
February 19, 2019
Providing methodological basis of MCDA with practical examples was the focus of a training organized by the Spain Chapter. The program included 2 session, the first began with a global lecture about innovation and the role of MCDA by Dr Álvaro Hidalgo. The second session begun with a Q&A time and presentation of application of MCDA in different settings.
Research Workshop on Economic Evaluation
29 November 2018; Madrid, Spain
ISPOR Spain Chapter Meeting
13 November 2018, Barcelona, Spain
During ISPOR Europe 2018, the ISPOR Spain Chapter delivered highly attended forum presentation, “Challenges in Medicines Funding for Rare Diseases,” and held a chapter meeting during which learnings from ISPOR 2018 conferences, updates on working groups, and new topics for the chapter agenda were shared with more than 80 chapter members. The reports from those activities can be viewed in the following links:
ISPOR Spain Chapter Meeting: February 7 2018; Madrid, Spain
The Evolution of Value in HealthcareMore than 200 professionals from the Spanish healthcare sector attended the meeting that focused on outcomes from the discussions that took place during the ISPOR 20th Annual European Congress in Glasgow, November 2017. The meeting was organized in collaboration with Diariofarma and provided an opportunity for those who did not attend the ISPOR conference to have an insight to main topics that were presented in the program.
The First Workshop of the ISPOR Spain Chapter; 8 June 2017; Madrid, Spain
Funding Models Proposal for the National Health System of the 21st Century
ISPOR Spain Chapter organized its first workshop held on 8 June 2017 at the Instituto de Salud Carlos III, Madrid, Spain and brought together all stakeholders involved in the price and reimbursement process for drugs and health technologies: General Administration of the State, Administration of the Autonomous Communities, academics, experts in pharmacoeconomics and industry.
The position of all the participants was unanimous; the system of pricing of drugs and health technologies in Spain requires changes. Very deep changes that go through the urgency to modify fundamental aspects in this process as the use of the economic evaluation, the transparency of its decisions, the procedures and the participation of the autonomous communities.
Dr Carme Pinyol, President of the ISPOR Spain Chapter, indicated that the economic crisis has meant a drop on health spending that has remained and is maintained once over. This decrease in health spending was necessary but its focus has been wrong, more emphasis has been placed on how much spending should be reduced rather than how to spend looking for the efficiency of the system. Linear cuts have been made that in the long term will be inefficient without thinking about what structural reforms would be necessary to implement to guarantee the sustainability of the system in the medium to long term.
It was mentioned that it was necessary a change in the model that should be produced through a legislative change that modernizes and adapts to this new environment.
(Reported by ISPOR Spain Chapter)
Jornada del Capitulo español de ISPOR
Propuesta de Modelos de Financiacion del SNS del Siglo XXI
Fecha: Jueves, 8 de junio de 2017
Horario: De 10.30h a 18.20h
Sede: Instituto de Salud Carlos III, Salon de Actos Ernest Lluch, C/Sinesio Delgado 10-12, Madrid
Comite Organizador los invita a participar en esta Jornada muy importante!
Adjunta esta el acta de la asamblea del pasado año en Viena aprobada en la asamblea del capitulo Espanol en Madrid el 8 de junio.
Acta de la Asamblea del Capitulo Espanol en Vienna, 2016
Congratulations to ISPOR Spain Chapter for their Outstanding Performance During the ISPOR 19th European Congress in Vienna, Austria
Very Productive Meeting and Constructive Forum at the ISPOR 19th Annual European Congress in Vienna!
ISPOR Spain Chapter had a great participation at the 19th European Congress in Vienna! ISPOR Spain Chapter Meeting and ISPOR Spain Forum: "The Spanish Experience in Hepatitis C; Friends or Foes? have been characterised by impressive attendance. The audience attending both events has been very enthusiastic and attentive. It worth to outline a great effort put into the preparation for both events by Chapter leadership headed by Carme Pinyol, prominent President of the ISPOR Spain Chapter.
During the chapter meeting in Vienna, the minutes form the last Spain Chapter meeting held in Murcia, June, 2016, have been read and approved (the minutes can be uploaded below).
ISPOR Spain Chapter Meeting Minutes (No. 2016/01)
Date: 15 June 2016
Location: Murcia, XXXVI Conference on Health Economics
Attendees: The Board of Directors: Carme Pinyol, Natividad Calvente, Carlos Marrtin, Ana Becerro, Jose Vicente Galindo
and Maria Dolores Vega. In addition 23 chapter members have been assisted.
Agenda: 1. Reading and approval of the previous chapter meeting minutes (No.2015/01). 2. Proposal of constitution as an association.3. Payment of quota and other ways of financing. 4. Working groups. 5. Spanish journal on Health Economics
Requests and questions followed the main agenda of the meeting.
The minutes from the ISPOR Spain Chapter meeting held in Vienna will be read and approved at the next chapter meeting.
Acta de la Asamblea del Capitulo Espanol en Vienna, 2016
|President||Carme Pinyol, MD, MSc|
|Vice President||Natividad Calvente|
|Past-President||Pedro Gómez Pajuelo, PhD|
|Secretary||Cristina Espinosa, MD|
|Treasurer||Carlos Martín Saborido, PhD|
|Director||Ana Becerro de Bengoa|
|Director||Jonathan Galduf, PhD|
|Director||Jose Vicente Galindo|
|Director||Alvaro Hidalgo Vega|
Chapter members attend the ISPOR Spain Chapter Meeting via Zoom on May 20, 2020
Forum speakers at ISPOR Europe 2018: Jordi Martí, Josep Torrent, Carme Pinyol, Marta Trapero
ISPOR Spain Chapter Workshop Attendees, 8 June 2017, Barcelona, Spain
ISPOR Spain Chapter Members after their Meeting in Vienna